Several optimized cell permeable stapled peptides disrupt RAB25:FIP complex formation in vitro and in situ, and oppose the context-specific phenotypes associated with RAB25 function in ovarian and breast cancer cell lines. Here, RAB25 is linked to breast carcinoma.